Skip to Main Content

Paper Details

Immunogenicity and safety of an investigational tetravalent recombinant subunit vaccine for dengue: results of a Phase I randomized clinical trial in flavivirus-naïve adults.
Human Vaccines and Immunotherapeutics
29
2019
DEN-80E, V180, aluminum, aluminum-hydroxide, dengue, dengue envelope proteins, flavivirus, human, participants, phosphate

Datasets

Release 1.2